BSEBoard Meeting4d ago · 11 Aug 2026, 02:38 pm

In compliance with Regulation 30 and 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform to the Exchange ....

Lactose India Ltd · 524202

✦ AI SummaryResults

Lactose India Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations at Rs. 4,696.84 lakhs and net profit after tax at Rs. 236.56 lakhs.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Lactose India Ltd - 524202 - Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday 11Th August, 2026

Attachments (1)

📄

9b061f0d-0715-4a1f-b293-af3d0fe683c2.pdf

pdf

Download →
View document text
BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai‐ 400001 Scrip code‐ 524202 Subject: Outcome of Board Meeting. Dear Sir, In compliance with Regulation 30 and 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform to the Exchange that the Board of Directors of the Company at their meeting held on Tuesday, 11th August 2026 has, inter alia, considered and approved the followings items of agenda: 1. Un‐audited Financial Results along with the Limited Review Report issued by the Statutory Auditor of the Company for the first quarter ended 30th June, 2026. The Meeting of the Board of Directors of the Company commenced at 12:00 Noon and concluded at 02:15 P.M. Kindly take the same on record and oblige. FOR LACTOSE (INDIA) LIMITED Atul Maheshwari Managing Director DIN: 00255202 Date: 11th August, 2026 Place: Mumbai Encl: As above Independent Auditor's Review Report on the Quarterly Unaudited Financial Results of the Lactose (INDIA) Limited under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. THE BOARD OF DIRECTORS, Lactose (INDIA) Limited 1. We have reviewed the accompanying statement of unaudited Ind AS financial results of Lactose (INDIA) Limited (“the Company”) for the Quarter ended 30th June 2026 being submitted by the Company in pursuant to the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 (“the Listing Regulations”). 2. This statement, which is the responsibility of the Company's Management and approved by the Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standards (IND AS) 34, “Interim Financial Reporting” prescribed under section 133 of the Companies Act 2013 read with relevant rules issued thereunder and accounting principles generally accepted in India and in compliance with Regulation 33 of the Listing Regulations. Our responsibility is to express a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements ('SRE') 2410, 'Review of Interim Financial Information Performed by the Independent Auditor of the Entity' issued by the Institute of Chartered Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether the Statement is free of material misstatement. A review is limited primarily to inquiries of company personnel and analytical procedures applied to financial data and thus provides less assurance than an audit. We have not performed an audit and accordingly, we do not express an audit opinion. 4. Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying statement of unaudited financial results prepared in accordance with applicable Indian Accounting Standards and accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 including the manner in which it is to be disclosed, or that it contains any material misstatement. For D M K H & Co. Chartered Accountants Firm Registration No.: 116886W CA Shikha Kabra Partner Membership No. 179437 UDIN: 26179437CHPWUE5297 Place: Mumbai Date: 11th August 2026 I NDIA LI MITE D LACTOSE(INDIA)LIMITED CIN:L15201GJ1991PLC015186 Regd.Off. :SurveyNo.5,6&7A,VillagePoicha(Rania),TalukaSavli,DistrictVadodara,Gujarat-391780. website:-www.Iactoseindialimited.com,EmailID:Iil@lactoseindialimited.com,Telephone:022-46644333 StatementofUnAuditedFinancialResultsfortheQuarter ended30thJune2026 (Rs.InLakhsExceptforEPS) QuarterEnded Particulars 30-Jun-26 31-Mar-26 30-Jun-25 31-Mar-26 UnAudited Audited UnAudit I I G.I Revenuefromoperations Revenuefromoperations 4,696.84 4,576.61 3,957.56 16,329.01 OtherIncome 55.98 41.46 21.54 107.18 Totalincome 4,752.82 4,598.15 3,999.02 16,436.20 Expenses (a)Costofmaterialsconsumed 3,249.18 2,828.28 1,563.63 8,752.02 (b)Changeininventoriesoffinishedgoods work-in-progress andstock-in-trade (613.46) (104.21) 676.67 763.82 (c)ManufacturingExpenses 785.70 655.94 2,553.86 617.57 (d)Employeesbenefitsexpenses 421.29 353.01 343.58 1,407.83 (e)FinanceCosts 176.41 142.97 508.60 122.01 (f)Depreciationandamortizationexpenses 163.76 150.09 574.22 137.28 (g)Otherexpenses 246.63 341.18 1,100.99 222.26 TotalExpenses 4,429.51 4,367.27 3,770.15 15,574.18 3 Profit/(Loss)beforetax 323.32 230.89 228.87 862.01 Exceptionalitems Profitbeforetax 323.32 230.89 228.87 862.01 4TaxExpense: CurrentTa(net) 67.60 38.54 38.20 143.89 DeferredTax(net) 19.16 26.79 40.81 133.97 TaofEarlierYears (22.13 (22.13 5 NetProfit/(Ioss)aftertax 236.56 187.69 149.86 606.28 6 OtherComprehensivelncomel(Ioss) ItemsThatwillnotbereclassifiedsubsequentlyinto Profitorloss Remeasurementofpostemploymentbenefitobligation 5.11 (1.82) IncomeTaeffectonabove (1.42 0.51 7 TotalComprehensiveincome/(Ioss),netoftax (5+6) 236.56 191.38 149.86 604.97 Paid-upequitysharecapital(FaceValueofRs.10each) 1,258,90 1,258.90 1,258.90 1,258.90 9 OtherEquity(excludlngrevaluationreserve) • 5,220.03 10 amingspershare (ofRs.101-each) notannualisedforthequarters) * L4`\ a)Basic(inRs.) A c 91 n 1.88 1.49 1.19 4.82 b)Diluted(inRs.) ' (YIN"\ 1.88 1.45 1.16 4.68 103-104,FirstFloor,"A"Wing,NavbharatEstate,ZakariaBunderRoad,Sewri(W),Mumbai-400015,India, Tel.:+91-22-46644333Email : lil@lactoseindialimited.com Website:www.lactoseindialimited.com Regd.Office -SurveyNo. 5,6&7A,Village: Poicha(Rania),TalukaSavli, District:Vadodara,Gujarat-391780, India. TWII\¢l9l1vahl.H CIN : Ll520lGJl99lpLcol5186 LACT SE I N DIA LI M ITED LACTOSE(INDIA)LIMITED CIN:L15201GJ1991PLC015186 Regd.Off.:SurveyNo.5,6&7A,VillagePoicha(Rania),TalukaSavli,DistrictVadodara,Gujarat-391780. website:-www.Iactoseindialimited.com,EmailID:Iil@lac:toseindialimited.com,Telephone:02246644333 StatementofUnAuditedFinancialResultsfortheQuarter ended30thJune2026 Notes: 1 TheaboveFinancialResultswerereviewedbytheAuditCommitteeandthereafterapprovedandtakenonrecordbytheBoardofDirectors attheirmeeting heldon nthAugust,2026.TheStatutoryAuditorsoftheCompanyhavecarriedoutlimitedreviewoftheaboveFinancial ResultspursuanttoRegulation33oftheSEBI(ListingObligations&DisclosureRequirements)Regulations,2015. 2 TheCompanyoperatesinonereportablebusinesssegmenti.e.'Pharmaceuticals". 3 IntermsofSEBI(IssueofCapitalandDisclosureRequirements)Regulations,2018,theCompanyupontheshareholdersapprovals,hason 05th December2024,issuedandallotted15,00,000Convertiblesharewarrants,ataissuepriceofRs. 174per Convertiblesharewarrants, 25% ofwhich amounting to Rs. 652.50 Lacs had received bytheCompanyfrom the respective Allottee'stowards subscription amount. Thesewarrants will be convertibleinto an equivalent number of Equity Shares offacevalue Rs.10 each at premium ofRs.164, in the Company,uponreceiptofbalanceissueprice,withinaperiodofeighteenmonthsfromthedateofallotment. Duringthequarterended30June2026,theperiodavailableforexercisingthesharewarrantsissuedbytheCompanyonapreferentialbasis expiredon5thJune2026.Thewarrantholdersdidnotexercisetheiroptionbyremittingthebalance75%ofthewarrantexercisepricewithin thestipulatedperiodprescribedunderthetermsofissueandtheapplicableSEBlregulations. Accordingly, the Board of Directors, at its meeting held on 18th June 2026 , approved the forfeiture of such unexercised warrants. Consequently,theupfrontamountof ?652.50 lakhs (being25% ofthewarrantissueprice) received atthetimeofallotmentofthesaid warrants has been forfeited and transferred to Capital Reserve in accordance with the terms of issue and the applicable regulatory requirements. 4 TheBoardofDirectors,atitsmeetingheldon23rdOctober2024,hadapprovedtheSchemeofArrangement("theScheme')formergerwith Vitanosh Ingredient [Showing first 8,000 characters — download PDF for full document]